The difference here is those companies have gone bust, but Axiom is highly improbable to follow their fate from here.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025